About Us
The Canadian Pharmaceutical Manufacturers and Exporters Alliance (CPMEA) represents Canadian pharmaceutical manufacturers operating production facilities in Canada, making medicines for Canadian patients and international markets. Our members are the largest manufacturers of medicines by volume in Canada, providing innovative, generic and biosimilar pharmaceuticals, and non-prescription medications. Our purpose is to highlight the importance of local pharmaceutical development and manufacturing for public health resilience and national security. A strong Canadian-based production network is essential to reduce Canada’s vulnerability to supply disruptions and heavy dependence on imported medicines. Through engagement with stakeholders, the Alliance brings together thought leaders to build a healthy future for domestic drug production and to ensure sovereignty of supply for Canadians.
Member Companies
With a legacy spanning 50 years, Apotex is dedicated to enhancing access to affordable and innovative medicines globally. As the largest Canadian-based pharmaceutical company, Apotex's broad portfolio and unwavering dedication to healthcare professionals and patients have solidified its position as a trusted partner. Notably, Apotex exports to 75 countries worldwide, further expanding its impact and reach in the pharmaceutical industry.
Founded in Canada in 1983, Pharmascience is a leading manufacturer of generic, branded, and over-the-counter pharmaceuticals, serving markets in over 50 countries. With a commitment to quality, R&D, and community service, Pharmascience has evolved from a modest start-up to a global player in the pharmaceutical industry, employing 1,500 individuals dedicated to excellence.
Established in Quebec over 40 years ago, Laboratoire Riva is a pioneer in manufacturing generic products, driven by cutting-edge technology and an unwavering commitment to customer service and innovation. With a dedicated team, Laboratoire Riva invests in research and development to ensure partner satisfaction and community growth.
Teva is a global pharmaceutical leader, serving over 200 million patients daily across 60 markets. Locally, Teva Canada has proudly met healthcare needs of Canadians for 60 years, filling over 175,000 prescriptions daily. We specialize in high-quality generic pharmaceuticals and innovative / biosimilar products in CNS, pain care, respiratory, and oncology. As one of Canada's first generic pharmaceutical companies, we continue to lead in providing quality medicines. At Teva, we are all in for better health.
Delpharm is a global leader in pharmaceutical contract manufacturing, partnering with major healthcare companies to deliver high-quality, cost-effective medicines. With over 35 years of experience, 18 manufacturing sites across Europe and Canada, and a strong focus on innovation, Delpharm offers expertise across a wide range of dosage forms. Its commitment to quality, sustainability, and continuous improvement has made Delpharm a trusted partner in ensuring reliable access to essential medications.
CPMEA’s member companies play a critical role in Canada’s pharmaceutical ecosystem and national economy. Together, they represent a significant share of Canada’s domestic manufacturing capacity and operate across multiple regions of the country.
Board Members
Terry Creighton
President, Canadian Pharmaceutical Manufacturers and Exporters Alliance
David Goodman
Executive Chairman,
Pharmascience
Allan Oberman
President & CEO,
Apotex Inc.
Olivier St. Denis
President
Laboratoire Riva, & Avir Pharma Inc.
Board Members
Terry Creighton
President,
Canadian Pharmaceutical Manufacturers and Exporters Alliance
Allan Oberman
President & CEO,
Apotex Inc.
David Goodman
Executive Chairman,
Pharmascience
Olivier St. Denis
President,
Laboratoire Riva & Avir Pharma Inc.
Fabien Paquette
General Manager,
Teva Pharmaceuticals
OUR VALUES
CANADA FIRST
Canadian pharmaceutical manufacturers are essential to a secure and reliable supply of medicines for Canadians. Domestic production reduces dependence on foreign sources, mitigates shortages, and ensures medicines are produced to the highest standards here at home. A strong manufacturing base is both a public health necessity and a strategic national economic asset.
OUR VALUES
ACCESS
We advocate for policies that ensure equitable and affordable access to essential medicines for all Canadians. Domestic manufacturers play a critical role in reducing barriers to access while supporting a healthcare system that delivers better outcomes and long-term sustainability.
OUR VALUES
TRUST
Trust is at the core of everything we do. Canadian pharmaceutical manufacturers are recognized globally for quality, safety, and regulatory excellence. Trust is earned through reliable supply, rigorous compliance, and an unwavering commitment to patient safety. Canadians can rely on domestic producers to deliver secure, high-quality medicines when they are needed most.
OUR VALUES
ECONOMIC SUSTAINABILITY
Canada’s pharmaceutical manufacturing sector is facing mounting pressure from global competition, rising costs, and evolving regulatory demands. The COVID-19 pandemic exposed the vulnerabilities of over-reliance on foreign supply chains and reinforced the necessity of local production. A sustainable domestic pharmaceutical manufacturing sector is critical to public health security and economic growth. CPMEA calls on all levels of government to prioritize Canadian pharmaceutical manufacturing as a strategic industry and to implement policies that support long-term investment, competitiveness, and supply sovereignty.